MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$49,942K
Interest income
$5,102K
Net loss
-$49,013K
Unrealized gain on
available-for-sale securities, net
-$929K
Total other income
$5,102K
Loss from operations
-$54,115K
Total operating
expenses
$54,115K
Research and development
$42,651K
General and
administrative
$11,464K
Back
Back
Income Statement
source: myfinsight.com
Edgewise Therapeutics, Inc. (EWTX)
Edgewise Therapeutics, Inc. (EWTX)